Trial intelligence / Profile preview

Curcuma aeruginosa cream vs ketoconazole cream for facial seborrheic dermatitis (split-face RCT)

TCTR20210416002Phase 3Recruiting

Sponsor
Thammasat University
Start
Apr 2021
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in seborrheic dermatitis (SD) (2 arms), sponsored by Thammasat University. Started Apr 2021; status: recruiting.

02

Conditions

seborrheic dermatitis (SD)

Beyond the preview

Go deeper on TCTR20210416002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210416002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call